Theophilus J. Gana
Gründer bei Biopharmatech Consulting, Inc.
Ursprung des Netzwerks ersten Grades von Theophilus J. Gana
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Biovail Corp.
 Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada.
11
| Extinct | Pharmaceuticals: Major | 11 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Theophilus J. Gana
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Pharma Patch Plc
 Pharma Patch Plc Pharmaceuticals: MajorHealth Technology Part of Packaged Home Solutions, Inc., Pharma Patch Plc produces pharmaceutical products. The company is based in Dublin, Ireland. Pharma Patch was acquired by Packaged Home Solutions, Inc. on November 17, 1995 for $17 million. | Pharmaceuticals: Major | Director of Finance/CFO | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| DNIB UNWIND INC | Biotechnology | Director/Board Member | |
| Rotman School of Management | College/University | Masters Business Admin | |
| INTELLIPHARMACEUTICS INTERNATIONAL INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of London | College/University | Doctorate Degree | |
| Carleton University | College/University | Undergraduate Degree | |
| VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
Biovail Pharmaceuticals LLC
 Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Biovail Pharmaceuticals, Inc. researches and develops pharmaceutical medicines. The company products include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director of Finance/CFO President | |
Breakaway Technologies, Inc.
 Breakaway Technologies, Inc. Packaged SoftwareTechnology Services Breakaway Technologies, Inc. develops analytic and business intelligence software. The private company is based in Yardley, PA. The company was founded by Darby Williams. | Packaged Software | Director of Finance/CFO | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Director/Board Member Human Resources Officer | |
| Pricewaterhousecoopers LLC | Comptroller/Controller/Auditor | ||
Novartis Venture Funds (USA)
 Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | Investment Managers | Private Equity Investor | |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director/Board Member | |
| Beecham Pharmaceuticals (UK) | Comptroller/Controller/Auditor | ||
| ACERUS PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Pinnacle Financial Corp. (Georgia)
 Pinnacle Financial Corp. (Georgia) Regional BanksFinance Pinnacle Financial Corp. provides banking services. The company was founded on October 21, 2002 and is headquartered in Elberton, GA. | Regional Banks | Chief Executive Officer | |
Trimel Biopharma, Inc.
 Trimel Biopharma, Inc. BiotechnologyHealth Technology Part of Acerus Pharmaceuticals Corp., Trimel Biopharma, Inc. develops biopharmaceutical products. The company is based in Mississauga, Canada. | Biotechnology | Director of Finance/CFO | |
| Toronto Institute of Pharmaceutical Technology | College/University | Corporate Officer/Principal | |
| Cogent Neuroscience, Inc. | Corporate Officer/Principal | ||
| AGILITY HEALTH, INC. | Hospital/Nursing Management | Director/Board Member | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Chief Executive Officer | |
| ALECTOR, INC. | Biotechnology | Director/Board Member | |
| VIKING THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Financial Executives International Philadelphia Chapter | Director/Board Member | ||
Merck Research Ventures
 Merck Research Ventures Investment ManagersFinance Merck Research Ventures (Merck Research) is a venture capital subsidiary of Merck Research Laboratories Massachusetts LLC founded in 2000. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
| APPILI THERAPEUTICS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Vertex Ventures HC
 Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
| GENERATION BIO CO. | Pharmaceuticals: Major | Director/Board Member | |
Redona Therapeutics, Inc.
 Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member | |
| ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
| ENTRADA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| BOUNDLESS BIO, INC. | Biotechnology | Director/Board Member | |
Tallac Therapeutics, Inc.
 Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA. | Biotechnology | Director/Board Member | |
| PATHWAY HEALTH CORP. | Medical/Nursing Services | Chairman | |
Pathway To Cures
 Pathway To Cures Investment ManagersFinance Pathway To Cures (Pathway To Cures) is a venture capital firm founded in 2022. The firm is headquartered in New York. | Investment Managers | Investment Committee Member |
Statistik
International
| Vereinigte Staaten | 30 |
| Kanada | 14 |
| Vereinigtes Königreich | 6 |
| Irland | 3 |
| Österreich | 2 |
Sektoral
| Health Technology | 32 |
| Finance | 6 |
| Consumer Services | 5 |
| Health Services | 5 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 84 |
| Independent Dir/Board Member | 26 |
| Corporate Officer/Principal | 26 |
| Director of Finance/CFO | 15 |
| Chief Executive Officer | 13 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Laurence Paul | 32 |
| Charles Rowland | 25 |
| Praveen Tyle | 23 |
| Christine Brennan | 20 |
| Kristine Peterson | 18 |
| Rob Harris | 11 |
| Kenneth Howling | 11 |
| Isa Odidi | 8 |
| Sheldon Plener | 6 |
| Mark Durham | 4 |
| Bruce D. Brydon | 2 |
- Börse
- Insiders
- Theophilus J. Gana
- Unternehmensverbindungen
